Trademark: 76360212
Word
EPIGENESISPHARMACEUTICALS.COM
Status
Dead
Status Code
606
Status Date
Sunday, July 2, 2006
Serial Number
76360212
Mark Type
1000
Filing Date
Monday, January 7, 2002
Published for Opposition
Tuesday, April 8, 2003
Abandoned Date
Sunday, July 2, 2006

Trademark Owner History
EPIGENESIS PHARMACEUTICALS LLC - 1st New Owner After Publication
EPIGENESIS Pharmaceuticals, Inc. - Owner At Publication

Classifications
5 medical diagnostic and therapeutic preparations and devices for administering same, sold filled with diagnostic and therapeutic preparations or separately as a kit, all for administration via diverse routes of administration, including through the respiratory airways, and medical devices for administering the pharmaceuticals, sold filled or separately as a kit, the preparations including polynucleotides, proteins and/or organic molecules for medical use, including macromolecules such as anti-sense oligonucleotides and enzymes and small organic and inorganic molecules for treatment of human and non-human animal respiratory, central nervous system, neoplastic, endocrine, immune and cardiovascular ailments, including bronchoconstriction, difficult breathing, impeded and obstructed lung airways, allergy(ies) and/or inflammation, which in some cases are adenosine receptor associated symptoms,; pharmaceutical preparations for testing, and preventing and therapeutically treating respiratory, airway and pulmonary diseases and conditions, such as asthma, pulmonary vasoconstriction, inflammation, allergies, impeded respiration, Acute Respiratory Distress Syndrome (ARDS), renal damage and failure, ischemia, resulting from the administration of certain drugs, including adenosine stress tests, infantile Respiratory Distress Syndrome (infantile RDS), pain, cystic fibrosis, allergic rhinitis, allergic bronchitis, pulmonary hypertension, pulmonary vasoconstriction, emphysema, chronic obstructive pulmonary disease (COPD), as well as cancers including leukemias, lymphomas, carcinomas, and the like, e.g., colon cancer, breast cancer, lung cancer, pancreatic cancer, hepatocellular carcinoma, kidney cancer, melanoma, etc., as well as all metastatic cancers, e.g.; cancers which metastasized to the lung(s), breast, liver and prostate included
EPI GENESIS PHARMACEUTICALS DOT COM

Trademark Events
Sep 7, 2006
Abandonment Notice Mailed - No Use Statement Filed
Sep 7, 2006
Abandonment - No Use Statement Filed
Dec 29, 2005
Extension 5 Granted
Dec 29, 2005
Extension 5 Filed
Dec 29, 2005
Teas Extension Received
Jul 1, 2005
Extension 4 Granted
Jul 1, 2005
Extension 4 Filed
Jul 1, 2005
Teas Extension Received
Jan 10, 2005
Extension 3 Granted
Dec 23, 2004
Extension 3 Filed
Dec 23, 2004
Teas Extension Received
Jul 28, 2004
Extension 2 Granted
Jun 30, 2004
Extension 2 Filed
Jul 16, 2004
Paper Received
Jul 19, 2004
Teas Change Of Correspondence Received
Jul 12, 2004
Case File In Ticrs
Jun 30, 2004
Teas Extension Received
Jan 22, 2004
Extension 1 Granted
Dec 31, 2003
Extension 1 Filed
Dec 31, 2003
Teas Extension Received
Jul 1, 2003
Noa Mailed - Sou Required From Applicant
Apr 8, 2003
Published For Opposition
Mar 19, 2003
Notice Of Publication
Jan 29, 2003
Approved For Pub - Principal Register
Oct 25, 2002
Sec. 1(B) Claim Added
Oct 25, 2002
Sec. 1(A) Claim Deleted
Oct 25, 2002
Correspondence Received In Law Office
Oct 25, 2002
Paper Received
Apr 26, 2002
Non-Final Action Mailed
Apr 8, 2002
Assigned To Examiner
Apr 4, 2002
Assigned To Examiner

Trademark Alertz updated from USPTO on 2030-01-24